Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL All other operating activities

All other operating activities at other companies

Haemonetics logo
HaemoneticsHAE
——

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's all other operating activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's all other operating activities?
QuidelOrtho Corporation (QDEL) reported all other operating activities of $4.9M in Q1 2026.
How has QuidelOrtho Corporation's all other operating activities changed year-over-year?
QuidelOrtho Corporation's all other operating activities decreased by 3.9% year-over-year, from $5.1M to $4.9M.
What is the long-term trend for QuidelOrtho Corporation's all other operating activities?
Over 2 years (2022 to 2025), QuidelOrtho Corporation's all other operating activities has grown at a -62.5% compound annual growth rate (CAGR), from $6.4M to $900K.